Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: A report from the Children's Oncology Group

Pediatric Blood and Cancer

Volumn 57, Issue 6, 2011, Pages 930-938

  Pressey, Joseph G ^a   Anderson, James R ^b   Crossman, David K ^c   Lynch, James C ^b   Barr, Frederic G ^d  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b Children's Oncology Group   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

GLI; Gorlin's syndrome; Hedgehog; Rhabdomyosarcoma; Undifferentiated sarcoma

Indexed keywords

PROTEIN PATCHED; RNA; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1;

ADOLESCENT; ARTICLE; CANCER PATIENT; CHILD; CONTROLLED STUDY; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SARCOMA; SCHOOL CHILD; SIGNAL TRANSDUCTION; UNDIFFERENTIATED SARCOMA;

CELL LINE, TUMOR; HEDGEHOG PROTEINS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CELL SURFACE; RHABDOMYOSARCOMA; RNA, MESSENGER; SARCOMA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 80052655551     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23174     Document Type: Article

References (27)

1. Ingham PW, McMahon AP. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 2001; 15: 3059-3087.
2. Ruppert JM, Vogelstein B, Kinzler KW. The zinc finger protein GLI transforms primary cells in cooperation with adenovirus E1A. Mol Cell Biol 1991; 11: 1724-1728.
3. Hahn HW, Zimmer L, Hall AM, et al. A. Rhabdomyosarcoma and radiation hypersensitivity in a mouse model of Gorlin Syndrome. Nat Med 1998; 4: 619-622.
4. Gorlin R. Nevoid basal-cell carcinoma syndrome. Medicine 1987; 66: 98-113.
5. Beddis IR, Mott MG, Bullimore J. Case report: Nasopharyngeal rhabdomyosarcoma and Gorlin's Naevoid basal cell carcinoma syndrome. Med Pediatr Oncol 1983; 11: 178-179.
6. Bridge JA, Liu J, Qualman SJ, et al. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 2002; 33: 310-321.
7. Tostar U, Malm CJ, Meis-Kindblom JM, et al. Deregulation of the hedgehog signalling pathway: A possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development. J Pathol 2006; 208: 17-25.
8. Zibat A, Missiaglia E, Rosenberger A, et al. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma. Oncogene 29: 6323-6330.
9. Lam CW, Xie J, To KF, et al. A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 1999; 18: 833-836.
10. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
11. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
12. Po A, Ferretti E, Miele E, et al. Hedgehog controls neural stem cells through p53-independent regulation of Nanog. EMBO J 29: 2646-2658.
13. Bale AE, Gailani MR, Leffell DJ. The Gorlin syndrome gene: A tumor suppressor active in basal cell carcinogenesis and embryonic development. Proc Assoc Am Physicians 1995; 107: 253-257.
14. Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002; 415: 436-442.
15. Berman DM, Karhadkar SS, Maitra A, et al. Widespread requirement for hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003; 425: 846-851.
16. Yoon JW, Kita Y, Frank DJ, et al. Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem 2002; 277: 5548-5555.
17. Bridge JA, Liu J, Weibolt V, et al. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: An intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer 2000; 27: 337-344.
18. Theunissen JW, de Sauvage FJ. Paracrine Hedgehog signaling in cancer. Cancer Res 2009; 69: 6007-6010.
19. Taylor MD, Liu L, Raffel C, et al. Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002; 31: 306-310.
20. Zwerner JP, Joo J, Warner KL, et al. The EWS/FLI1 oncogenic transcription factor deregulates GLI1. Oncogene 2008; 27: 3282-3291.
21. Pawel BR, Hamoudi AB, Asmar L, et al. Undifferentiated sarcomas of children: Pathology and clinical behavior-An Intergroup Rhabdomyosarcoma study. Med Pediatr Oncol 1997; 29: 170-180.
22. Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 2001; 19: 3091-3102.
23. Dierks C. GDC-0449-Targeting the hedgehog signaling pathway. Recent Results Cancer Res 184: 235-238.
24. Rudin CM, Hann CL, Laterra J, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009; 361: 1173-1178.
25. Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009; 361: 1164-1172.
26. Yauch RL, Dijkgraaf GJ, Alicke B, et al. Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma. Science 2009; 326: 572-574.
27. Lauth M, Bergstrom A, Shimokawa T, et al. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA 2007; 104: 8455-8460.